Web Analytics

3 Latest Announced Rounds

  • $100,000,000
    Series C

    6 Investors

    Biotechnology Research
    Jan 21st, 2025
  • $55,157,175
    Unknown

    2 Investors

    Investment Management
    Jan 21st, 2025
  • $1,000,000
    Seed
    Software Development
    Jan 21st, 2025
$1,083.28M Raised in 34 Funding Rounds in the past 7 Days - View All

Funding Round Profile

DiogenX

start up
France - Marseille
  • 11/05/2023
  • Series A
  • $30,056,125

DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world.
Our lead program, originating from Dr Patrick Collombat’s laboratory, is based on a new approach targeting beta-cell failure throughout the stimulation of beta-cell functional recovery in diabetes. This novel mode of action will provide a unique solution to rebalance glucose/insulin homeostasis and thus offer clear clinically meaningful benefits.
DiogenX is headquartered in Marseille, with labs in Nice (France).


Related People

Benjamin CHARLESFounder

Benjamin CHARLES France - Marseille, Provence-Alpes-Côte d'Azur

N/A